Table 1: Demographic, clinical and serological features of the study population.
Parameter |
pSS patients with PN No = 13 |
pSS patients without PN No = 83 |
Age- Mean (min, max) |
49 (34, 61) |
53 (19, 83) |
Sex- Women |
13 (100%) |
81 (97.5%) |
Xerophthalmia |
10 (76.9%) |
71 (85.5%) |
Xerostomia |
9 (69.2%) |
65 (78.3%) |
ANA positivity, n (%) |
11 (84.6%) |
68 (81.9%) |
Anti-Ro/SSA antibodies, n (%) |
9 (69.2%) |
70 (84.3%) |
Anti-La/SSB antibodies, n (%) |
6 (46.1%) |
50 (60.2%) |
Rheumatoid factor positivity, n (%) |
3 (23.1%) |
65 (78.3%) |
Iron level (µg/dL)* |
73.42 ± 26.69 |
71.70 ± 29.09 |
Folic acid level (ng/mL)* |
8.75 ± 3.44 |
9.55 ± 4.47 |
25(OH) Vitamin D level (ng/mL)* |
24.92 ± 12.03 |
27.01 ± 13.48 |
Pure sensory neuropathy |
8 (61.5%) |
- |
Sensorimotor neuropathy |
2 (15.3%) |
- |
Small fiber neuropathy |
5 (38.4%) |
- |
PN: Peripheral Neuropathy; Pss: Primary Sjögren Syndrome
*Mean ± standard deviation